Literature DB >> 19808197

Myasthenia gravis and autoimmune Addison disease in a patient with thymoma.

Mesut Seker1, Hulya Iliksu Gozu, Bala Basak Oven Ustaalioğlu, Berkant Sonmez, Fatih Yavuz Erkal, Mihriban Kocak, Nagehan Ozdemir Barisik, Ekrem Orbay, Mehmet Sargin, Haluk Sargin, Ulku Turk Boru, Mustafa Yaylaci.   

Abstract

The association of thymoma with myasthenia gravis has been well documented. However, the relationship between these two syndromes and Addison disease are very rarely encountered in clinical practice. We report on a 32-year-old man who underwent a resection for thymoma 48 months ago. The diagnosis of Addison disease was made followed by a diagnosis of myasthenia gravis on the basis of a high titer of acetylcholine receptor levels. The treatment of oral prednisolone 7.5 mg/day and oral prostigmine 180 mg/day was initiated. His symptoms and physical signs were improved after this treatment. To our knowledge, this is the fourth reported case of thymoma synchronously associated with myasthenia gravis and Addison disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19808197     DOI: 10.3816/CLC.2009.n.051

Source DB:  PubMed          Journal:  Clin Lung Cancer        ISSN: 1525-7304            Impact factor:   4.785


  3 in total

1.  Clinical and serologic parallels to APS-I in patients with thymomas and autoantigen transcripts in their tumors.

Authors:  Anette S B Wolff; Jaanika Kärner; Jone F Owe; Bergithe E V Oftedal; Nils Erik Gilhus; Martina M Erichsen; Olle Kämpe; Anthony Meager; Pärt Peterson; Kai Kisand; Nick Willcox; Eystein S Husebye
Journal:  J Immunol       Date:  2014-09-17       Impact factor: 5.422

2.  Clinical and Genetic Characteristics of Thymoma Patients With Autoimmune Hepatitis and Myocarditis.

Authors:  Xin-Tao Yu; Lei Yu; Xin Du; Zhen Yu; Xing-Guo Yang; Yu-Xuan Jiang
Journal:  Front Oncol       Date:  2022-01-07       Impact factor: 6.244

3.  Autoimmune polyglandular syndrome type 2 and autoimmune hepatitis with thymoma-associated myasthenia gravis: case report.

Authors:  Hidefumi Inaba; Hiroyuki Ariyasu; Hiroshi Iwakura; Chiaki Kurimoto; Yoko Ueda; Shinsuke Uraki; Ken Takeshima; Yasushi Furukawa; Shuhei Morita; Yoshiaki Nakayama; Takuya Ohashi; Hidefumi Ito; Yoshiharu Nishimura; Takashi Akamizu
Journal:  BMC Endocr Disord       Date:  2020-04-07       Impact factor: 2.763

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.